Two-Color Lymphatic Mapping Using Ig-Conjugated Near Infrared Optical Probes  by Hama, Yukihiro et al.
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To map the drainage patterns of the lymphatic system, multicolor optical probes must be developed, which can
be interstitially administered. These agents must be of sufficient size to be retained by the lymphatic system and
permit the conjugation or incorporation of fluorescent probes with varying emission wavelengths. Quantum
dots fulfill these criteria, but their potential toxicity limits their application to research settings. Here, we
describe the synthesis of lymphatic optical probes based on Igs conjugated with Cy5.5 and Cy7 and
demonstrate in animal models that these agents can map the lymphatic drainage patterns within axillary nodes
draining both the breast and upper extremity, cervical nodes draining both the ear and upper extremity, and
sentinel lymph nodes draining different anatomic locations. The ability to separately and simultaneously
visualize the drainage patterns from two separate lymphatic vessels may have implications for the preoperative
mapping of lymph nodes before lymph node resection. The biocompatibility of fluorescently labeled Igs in
comparison to other nanoparticulate fluorophores improves the chances of clinical translation. This
noninvasive and biocompatible multicolor method of optical lymphangiography may elucidate the complex
human lymphatic system and reduce the risk of lymphedema after surgery for melanoma and other cancers.
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INTRODUCTION
The use of multicolor optical probes has opened up the
possibility of visualizing the simultaneous drainage of two
separate lymphatic channels that drain into shared lymph
nodes such as the axillary and cervical lymph node chains.
This could allow specific nodes within a nodal cluster to be
spared or resected during lymphadenectomy depending on
its drainage pattern. By sparing unaffected lymph nodes
postoperative lymphedema could be reduced or eliminated.
Recent developments in in vivo optical lymphangiography
using near infrared (NIR) probes could have great potential in
cancer diagnosis as well as image-guided surgery (Kim et al.,
2004; Hama et al., 2007).
Owing to the higher tissue penetration of photons in the
NIR range compared with photons in the visible range,
nanoparticles such as quantum dots (Qdots), which emit light
in the NIR, have been used to generate two-color lymphatic
drainage maps that clearly visualize the separate and
simultaneous flow of lymph from the different injection sites
in the body and their converging points within specific nodes
(Hama et al., 2007). However, because of concerns about the
potential toxicity of Qdots (Hardman, 2006; Zhang et al.,
2006), nontoxic, biocompatible alternatives have been sought.
Prior studies of lymphatic flow have been performed with
radiolabeled nanoparticles. Although, radiolabeled sulfur
colloid and albumin have been used for sentinel node
imaging, radiolabeled IgG has also been considered both
clinically feasible and desirable because of the rapid
migration of the IgG-labeled tracers through the lymphatics
from the injection site, their low vascular permeability, and
their minimal toxicity (Pain et al., 2002; O’Mahony et al.,
2006). However, g-imaging with radiolabeled IgG has several
limitations such as poor spatial resolution and ionizing
radiation exposure. Additionally, it is difficult to separately
map the drainage patterns from two converging lymphatic
systems with radionuclide imaging since there are no
characteristic signal differences between one lymphatic
system and the other.
IgGs are biocompatible and readily conjugated to NIR
probes that vary in their emission wavelength. Therefore, IgG
is attractive as a nanoparticle with which to image the
lymphatic system. Moreover, optical fluorescence imaging
allows multiple colors to be used simultaneously while
achieving high temporal and spatial resolution without
exposure to ionizing radiation. Compared to radionuclide
imaging, optical imaging equipment is inexpensive and
portable. Herein, we describe the synthesis of IgG-conju-
gated NIR optical agents for use as lymphatic agents for
mapping converging drainage systems and for sentinel node
imaging.
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RESULTS
Two-color in vivo spectral lymphangiography clearly visualizes
converging lymphatic channels and maps their drainage
territory
Two-color in vivo NIR spectral resolved lymphangiography
was performed with interstitial injections of IgG-conjugated
Cy5.5 (IgG-Cy5.5) in the breast and IgG-conjugated Cy7
(IgG-Cy7) in the upper extremity. In all five mice, sentinel
nodes were identified as early as 1 minute after the injection
of the mammary fat pad with IgG-Cy5.5 or IgG-Cy7 (Figure
1a). The opacification lasted for 30 minutes but gradually
decreased 30 minutes after injection especially in the
lymphatic ducts. Lymph nodes were visualized within a few
minutes and retained the agent for at least 90 minutes
postinjection. This would be a long enough time for most
clinical procedures. All left axillary lymph nodes (n¼ 5) in
five mice had mixed contributions from the breast and the
upper extremity. The watersheds within individual axillary
lymph nodes were clearly visualized in three mice (Figure
1a). The lateral thoracic lymph nodes were identified only
after the skin was removed and lateral thoracic lymph nodes
were pulled away from the mammary pads because of the
interference by light from the injection site in the adjacent
breast tissue. When the skin and the subcutaneous adipose
tissue were surgically removed, the lymphatics from the
upper extremity, the axillary, and lateral thoracic lymph
nodes were more distinctively visualized (Figure 1b). The
closeup ex vivo image of extracted lymph nodes demon-
strated that all five axillary and five lateral thoracic lymph
nodes had mixed contributions from the breast and the upper
extremity (Figure 1c). These in vivo and ex vivo imaging
findings were validated by fluorescence microscopy of frozen
sections of axillary (Figure 2a) and lateral thoracic (Figure 2b)
lymph nodes. The fluorescence intensity of the lymph node
cortex was much weaker than that of the lymph node
medulla. The watersheds of two different lymphatic drainages
were clearly seen in frozen sections of all 10 lymph nodes
examined. Several specimens demonstrated that the lympha-
tic territorial boundaries between IgG-Cy5.5 and IgG-Cy7
were seen at the site of the efferent lymphatic vessels
although the angle of the cut-end surface was critical to this
determination (Figure 2b).
With IgG-Cy5.5 injections in the left upper extremity and
the right lower extremity and IgG-Cy7 in the right upper
extremity and the left lower extremity, whole body lymphan-
giography images clearly depicted the mixing lymphatic
draining basins of the four extremities as well as the bilateral
sentinel lymph nodes (axillary and external iliac lymph
nodes) in all three mice (Figure 3). No lymph node received
lymphatic drainage from the contralateral side of the upper or
lower extremity.
With injections of IgG-Cy5.5 in the right ear and the left
upper extremity and IgG-Cy7 in the left ear and the right
upper extremity, the lateral thoracic lymph nodes were
identified as opacifying via the ipsilateral upper extremities
while the cervical lymph nodes received lymphatic drainage
from the ipsilateral ears (Figure 4a). The findings of in vivo
lymphangiography performed through the skin completely
matched the results obtained after surgical removal of the
skin and the subcutaneous adipose tissue (Figure 4b). As the
cervical lymph nodes were located in the deep subcutaneous
tissue, all six cervical lymph nodes required the depth
penetration afforded by NIR probes during the surgical
procedure (Figure 4c). In contrast to the axillary nodes where
convergence was common, no cervical lymph node received
lymphatic flow simultaneously from two or more sites.
Adverse effects
No redness or induration was found at the injection site at 2
and 7 days after injection of either IgG-Cy5.5 or IgG-Cy7 in
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Figure 1. In vivo and ex vivo spectral fluorescence imaging. Imaging of a
mouse injected with IgG-Cy5.5 in the left mammary pad and IgG-Cy7
intracutaneously in the middle phalange of the left upper extremity. (a) In vivo
white light and (b and c) spectral resolved fluorescence images before surgical
removal of the skin. The axillary lymph node (Ax.) received two different
lymphatic flows simultaneously from the breast and the upper extremity.
Lymph nodes (red arrow) as well as the lymphatic vessels (green arrows) were
clearly visualized through the skin. (d) The composite image consists of the
spectral unmixed IgG-Cy5.5 (red) and IgG-Cy7 (green) images. (e) In vivo
composite image of the mouse shown in panel a after surgical removal of the
skin. This image is composed of IgG-Cy5.5 (red) and IgG-Cy7 (green)
spectral fluorescence images. The lymphatic draining ducts (white arrow)
from the upper extremity in addition to the Ax. and the lateral thoracic
(LT) lymph nodes were clearly depicted. The Ax. and the LT lymph
nodes received lymphatic drainages simultaneously from the breast and
the upper extremity. But the intralymphatic watershed (arrowhead) was
visualized only in the Ax. lymph node. (f) Ex vivo spectral fluorescence
imaging of the Ax. and the LT lymph nodes in the same mouse. The distal
half of the Ax. lymph node received the lymphatic drainage from the upper
extremity and the proximal half of it received the lymphatic drainage from the
breast, resultantly the boundary between the two different lymphatic flows
was shown within the same lymph node. The LT lymph node also received
the lymphatic flows simultaneous from the breast and the upper extremity, but
intralymphatic boundary or watershed was not depicted even though the
lymph node was imaged from all angles.
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immunocompetent Balb/c mice (Figure 5a). In addition, the
light blue staining of Cy55 or Cy7, which was found
immediately after injection, disappeared within 2 days
(Figure 5a). No inflammatory change was detected in the
axillary lymph nodes by histology either 2 or 7 days after
injection (Figure 5b). All four mice in each group showed
similar findings.
DISCUSSION
Localizing sentinel lymph nodes and assessing lymphatic
drainage function are clinically important for the treatment of
melanoma and other types of malignancies (e.g., breast
cancer, cervical cancer, head and neck cancer). For the past
few decades, noninvasive imaging modalities such as
computed tomography, magnetic resonance imaging, and
positron emission tomography have allowed reasonably
precise localization of abnormal lymph nodes (Mackie
et al., 2003). However, these methods provide only anatomic
and not functional maps of the drainage pattern of the
lymphatics. The lymphatic drainage pattern is of clinical
importance if complications such as lymphedema are to be
avoided after lymphatic resection (Erickson et al., 2001;
Cheville et al., 2003; Mariani et al., 2004; Abu-Rustum et al.,
2006; Bergmark et al., 2006). A functional lymphatic imaging
modality would require a nanoparticle backbone that is
retained by the lymphatics and is attached to a multichannel
imaging beacon to distinguish one lymphatic drainage system
from another (Kobayashi et al., 2003, 2004; Hama et al.,
2006). Moreover, to be useful as a sentinel node agent, it
should provide enough depth sensitivity to enable localiza-
tion of the node through the skin. The imaging probe
described here fulfills these criteria. The nanoparticle uses
an IgG backbone that is already in human use. The NIR
fluorophores, which are conjugated to the IgG, permit
multicolor imaging with reasonable depth penetration
(E5 mm), although further work is required to optimize these
probes for clinical application (e.g., choice of optimal
wavelength).
Lymphedema results when lymphatic resection removes
normally draining vessels causing lymph flow to back up
proximal to the blockage. To minimize the risk of lymphe-
dema, detailed anatomical and functional imaging of
lymphatics and sentinel lymph nodes is important for the
accurate planning of surgery as well as radiation therapy.
Optical imaging could be used during surgery as it uses no
ionizing radiation and the cost of the agent and the imaging
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Figure 2. Fluorescence microscopy of the extracted axillary lymph nodes
validated the in vivo and ex vivo imaging findings. (a) Differential
interference contrast (DIC) (black white images) and fluorescence microscopy
(color images) of extracted axillary lymph node in the same mouse shown in
Figure 1. The two-color fluorescence microscopy more clearly and reliably
demonstrated the intralymphatic drainage territory as well as the watershed of
the two different lymphatic flows (interface between the IgG-Cy5.5 (red) and
the IgG-Cy7 (green)) in all five axillary lymph nodes examined. However, the
fluorescence intensity of both IgG-Cy5.5 and IgG-Cy7 in the lymph node
cortex was relatively lower than that of the medulla (arrowheads). Original
magnification  40. The black spots on the DIC image are bubble artifacts.
(b) DIC and fluorescence microscopy of extracted lateral thoracic lymph node
in a mouse different from that of Figure 1. (c) The lymphatic flow territories
of IgG-Cy5.5 and IgG-Cy7 were clearly separated in all five lateral thoracic
lymph nodes examined and the territorial boundaries were made at the
efferent duct (arrow) of the hilum in this lymph node. The fluorescence
microscopy findings were compatible with the in vivo optical
lymphangiography in all mice. The filters used for excitation and emission
were 590–650 and 665–730 nm for IgG-Cy5.5 and 675–745 and 770–850 nm
for IgG-Cy7, respectively. Bar¼ 1 mm.
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Figure 3. Whole body spectral-resolved fluorescence lymphangiography of
the four extremities clearly visualized each lymphatic and sentinel lymph
node. IgG-Cy5.5 was injected into the middle phalange of the left upper
extremity and into the middle digit of the right lower extremity and IgG-Cy7
was injected into the middle phalange of the right upper extremity and into
the middle digit of the left lower extremity. (a) Immediately after injections,
spectral resolved fluorescence imaging clearly depicted the lymphatics (blue
arrows) of the four extremities as well as the bilateral axillary (Ax.) (pink
arrows) and the external iliac (E.I.) (yellow arrows) lymph nodes. (b) IgG-
Cy5.5 was more fluorescent than (c) IgG-Cy7 at the superficial regions (e.g.,
lymphatics of the upper extremity) but it became less fluorescent at the deeper
regions (e.g., Ax. and E.I. lymph nodes) partially because the photon
penetration of IgG-Cy5.5 is less than that of IgG-Cy7 but the excitation
efficiency of IgG-Cy5.5 is higher than that of IgG-Cy7.
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equipment is potentially very low. Therefore, the use of
fluorescence imaging could guide partial sentinel node
lymphadenectomy, which could reduce damage to the
lymphatic drainage, and thus, avoid lymphedema. The
current report focuses on establishing a biocompatible and
noninvasive multicolor lymphangiographic method to map
lymphatic drainage from various parts of the body. The results
of optical in vivo lymphangiography reported here are
consistent with a previous optical lymphangiographic study
using Qdots (Hama et al., 2006), but differ in that the agent
used (IgG) is substantially less toxic than Qdots. Optical
imaging with IgG conjugated to NIR fluorescent dyes is
considerably more clinically feasible than Qdot imaging
(Hardman, 2006; Zhang et al., 2006). This technique could
also be used to track the lymphatic passage of injected
proteins or drugs which are comparable in molecular weight
to IgG, monitor cutaneous reactions to vaccines (Stamatas
et al., 2006), and assist image-guided surgery for the
treatments of melanoma, other malignancies, and lymphatic
diseases (Koshima et al., 2000; Scarsbrook et al., 2006).
With the use of organic dyes, (Wunderbaldinger et al.
(2003) reported the NIR fluorescence imaging of lymph
nodes using a Cy5.5-based cathepsin-B-activatable optical
probe. The probe was also used for cancer detection after
systemic administration (Mahmood et al., 1999), so that the
accumulation might not be specific for lymph nodes. After
the probe was activated, it had high affinity for the lymph
nodes, resulting in high signal-to-background ratios. How-
ever, the lymphatic ducts were not seen properly. In addition,
the use of a synthetic peptide poses the theoretical risk of
immunogenicity in man (Van Regenmortel, 2001).
It is interesting that the fluorescence intensity of the cortex
of the lymph nodes was very much lower than that of the
nodal medulla (Figure 2a and b). This result differs from the
pattern of enhancement using Qdots for two-color lymphan-
giography where both the cortex and medulla enhanced
equally (Hama et al., 2006). The most probable reason is that
most of the macrophages and the natural killer cells are
present in or near the medullary sinus while the lymph node
cortex is occupied with B cells which group together to form
spherical lymphoid follicles. After interstitial injection with
IgG-conjugated NIR fluorophores, these dyes enter the cortex
through the afferent lymphatic vessels, drain into the
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Figure 4. Spectral-resolved lymphangiography after injections in the
bilateral ears and the upper extremities clarified the lymphatic network.
(a) Composite image consisting of (b) spectral unmixed IgG-Cy5.5 (c) and
IgG-Cy7 images before surgical removal of the skin. The cervical lymph
node (Ce.) (yellow arrows) received the lymphatic flow exclusively from
the ipsilateral ear while the lateral thoracic lymph node (LT) (blue arrows)
received the lymphatic flow exclusively from the ipsilateral upper extremity.
(d) Composite image after surgical removal of the skin and the subcutaneous
tissues validated the in vivo images before surgery. The cervical lymph nodes,
which received the drainages from the ears, were located in the deep
subcutaneous tissue where the visual distinction between the lymph node and
the subcutaneous adipose tissue was impossible. Thus, localization of each
cervical lymph node was performed under NIR image guidance. (e) Color
photograph of the same mouse shown in panels a and b. The bilateral cervical
lymph nodes, which received lymphatic drainage from the ipsilateral ears
were localized by tweezers. Visual distinction between the lymph nodes
and the surrounding subcutaneous tissue was impossible.
a
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Figure 5. No apparent adverse effect of fluorescent probes was found either
at the injection site or the sentinel lymph node. Serial photographs of the
injection sites (arrows) of (a) mIgG-Cy5.5 (b) and mIgG-Cy7 are shown. No
redness or induration was found at the injection site at days 2 and 7 after
injection of either IgG-Cy5.5 or IgG-Cy7. In addition, the light blue staining of
Cy5.5 or Cy7, which was found immediately after injection, disappeared
within 2 days. Serial histological images of hematoxylin and eosin-stained
axillary lymph node sections, which were obtained and processed 2 and 7
days after injection with (c, left phalange) mIgG-Cy5.5 and (d, right phalange)
mIgG-Cy7 are shown. No inflammatory change was detected in the axillary
lymph nodes either 2 or 7 days after injection. Bar¼ 1 mm. All four mice in
each group showed similar findings.
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medullary sinus, and are then trapped by the macrophages
and natural killer cells because these cells have a number of
Fc receptors (FcgR) which bind the Fc fragments of polyclonal
IgG (Fleit et al., 1982; Figure S1). But B cells have no Fc
receptors, thus IgG will not be trapped by the lymph node
cortex. In contrast, Qdots are nonspecifically trapped
throughout the node. An additional reason for preferential
accumulation of IgG in the medulla relates to the dynamics of
intranodal lymphatic flow. Lymph enters a lymph node
through multiple afferent lymphatic vessels and then moves
into the medullary sinus and finally exits the lymph node
through a single or, at most, a small number of efferent
lymphatic vessels. In general, there are fewer efferent
lymphatic vessels than afferent lymphatic vessels, therefore,
lymph flow substantially slows around the medullary sinus.
This allows time for IgG to stay longer in the medullary
sinus and for macrophages and natural killer cells to bind
sufficiently to IgG.
In conclusion, our study shows that multicolor
spectrally resolved fluorescence lymphangiography using an
IgG–NIR probe conjugate is capable of visualizing the
lymphatic flows from different lymphatic basins while using
a biocompatible and clinically feasible optical probe. These
anatomical and functional imaging data may help surgeons
and radiation oncologists avoid disrupting the lymphatic
flows from the normal organs and thereby reduce the risk of
lymphedema.
MATERIALS AND METHODS
Synthesis of IgG-conjugated NIR fluorescence dyes
A purified mouse polyclonal IgG was purchased from Sigma
(St Louis, MO). Amine-reactive Cy5.5 (peak emission wavelength
at 691 nm) and Cy7 (peak emission wavelength at 776 nm) were
purchased from GE Healthcare Limited (Piscateway, NJ). At room
temperature, 2 mg (13.3 nmol) of IgG in Na2HPO4 was incubated
with 70 nmol (7 ml/10 mM) of Cy5.5 and Cy7, respectively, in DMSO
at pH 8.5 for 15 minutes. The mixture was purified with Sephadex
G50 (PD-10; GE Healthcare, Milwaukee, WI). IgG-conjugated Cy5.5
and Cy7 samples (IgG-Cy5.5 and IgG-Cy7, respectively) were kept at
41C in the refrigerator as stock solutions.
The protein concentration of IgG-Cy5.5 and IgG-Cy7 samples
was determined with Coomassie Plus protein assay kit (Pierce Chem
Co., Rockford, IL) by measuring the absorption at 595 nm with a UV-
Vis system (8453 Value UV-Bis system, Agilent Technologies, Palo
Alto, CA) using standard solutions of known concentrations of IgG
(100, 200, and 400 mg/ml). Then, the concentration of Cy5.5 and
Cy7 were measured by the absorption at 679 and 756 nm
respectively with a UV-Vis system (8453 Value UV-Bis system,
Agilent Technologies) to confirm the number of fluorophore
molecules conjugated with each IgG molecule. By changing the
concentration of IgG solution to 4 mg/ml, the number of fluorophore
molecules per IgG was adjusted to be two.
In vivo wavelength-resolved spectral fluorescence imaging
All in vivo procedures were carried out in compliance with the
Guide for the Care and Use of Laboratory Animal Resources (1996),
National Research Council, and approved by the National Cancer
Institute Animal Care and Use Committee. Normal athymic mice
(10-week-old) were killed with intraperitoneal injection of 1.15 mg
sodium pentobarbital (Dainabot, Osaka, Japan). Then, five mice
were given intracutaneous injections of 5 ml (130 pmol) IgG-Cy7 in
the middle phalange of the left upper extremity and subcutaneous
injection of 10ml (270 pmol) of IgG-Cy5.5 in the left breast.
Another three mice received intracutaneous injections of 5 ml
(40 pmol) IgG-Cy5.5 each in the middle phalange of the left upper
extremity and the middle digit of the right lower extremity and
intracutaneous injections of 5ml (130 pmol) IgG-Cy7 each in the
middle phalange of the right upper extremity and in the middle digit
of the left lower extremity. When IgG-Cy5.5 is injected into the
superficial subcutaneous tissue, IgG-Cy5.5 will be excited more
effectively by the excitation light (excitation wavelength
590–650 nm) than IgG-Cy7, thus the concentration of IgG-Cy5.5
was reduced to obtain the comparable emission light in intensity to
IgG-Cy7.
Another three mice underwent intracutaneous injections of 5 ml
(40 pmol) IgG-Cy5.5 each in the middle phalange of the left upper
extremity and the right ear and intracutaneous injections of 5 ml
(130 pmol) IgG-Cy7 each in the middle phalange of the right upper
extremity and the left ear.
Immediately after injection of the IgG-Cy5.5 and IgG-Cy7,
wavelength-resolved spectral imaging was carried out using a
spectral imaging system (Maestro In-Vivo Imaging System, CRI
Inc., Woburn, MA). Mice were placed in prone and spine positions
and in the right lateral decubitus position. The excitation band pass
filter 575–605 nm was used. The tunable filter was automatically
stepped in 10-nm increments from 600 to 950 nm with the same
exposure time for images captured at each wavelength. Collected
images were analyzed by the Maestro software, which uses spectral
unmixing algorithms to separate autofluorescence, fluorescence
from IgG-Cy5.5 and IgG-Cy7, and composite image consisting of
IgG-Cy5.5 and IgG-Cy7 signals and autofluorescence was obtained.
Fluorescence microscopy
Mice were killed with intravenous injection of sodium pentobarbital
1 hour after injection of IgG-Cy5.5 and IgG-Cy7. For the five mice
injected in the middle phalange of the left upper extremity and the
left breast, the axillary, lateral thoracic, and cervical lymph nodes
were collected and frozen in Tissutek (Sakura, Torrance, CA) and
stored at 801C. Frozen samples were sectioned by a cryostat
microtome (CM1800; Leica, Bannockburn, IL) at a thickness of
30 mm. Slides were analyzed under an Olympus BX51 microscope
(Olympus America Inc., Melville, NY) equipped with the following
filters: Cy5 cube set for IgG-Cy5.5; excitation wavelength
590–650 nm, emission wavelength 665–730 nm band pass, Cy7
cube set for IgG-Cy7; excitation wavelength 675–745 nm, emission
wavelength 770–850 nm band pass.
Adverse effects
To determine if this method produced adverse effects, eight of 11
immunocompetent Balb/c mice were intracutaneously injected with
the same dose of IgG-Cy5.5 in the left middle phalange and IgG-Cy7
in the right middle phalange in the upper extremity as performed in
the imaging study. The remaining three mice were used as ‘‘no
injection’’ controls. The injection sites of skin were observed
immediately after injection, days 2, and 7 after injection. Four out
of eight injected mice and another four mice were killed at days 2
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and 7 after injection, respectively, and the axillary lymph nodes
were resected for histological analysis. All tissues were fixed in 10%
formaldehyde, stained with hematoxylin and eosin, and examined
for inflammatory changes.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
This research was supported by the Intramural Research Program of the NIH,
National Cancer Institute, Center for Cancer Research.
SUPPLEMENTARY MATERIAL
Figure S1. Murine IgG accumulated better in the lymph node than human IgG
in mice.
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